UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 8, 2015

LANTHEUS HOLDINGS, INC.
(Exact name of registrant as specified in its charter)

 
 	 	 	 	 	
Delaware	 	001-36569	 	35-2318913	
(State or other jurisdiction
of incorporation)	 	(Commission
File Number)	 	(IRS Employer
Identification No.)	
331 Treble Cove Road, North Billerica, MA 01862
(Address of principal executive offices) (Zip code)
Registrant’s telephone number, including area code: (978) 671-8001
Not Applicable
(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)	
 
¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)	
 
¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))	
 
¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))	

 

Item 5.02	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers	
On December 10, 2015, Lantheus Holdings, Inc. (the “Company”) announced the resignation of John K. Bakewell as the Chief Financial Officer and Treasurer of the Company and its subsidiaries, effective as of December 10, 2015. The Company’s Board of Directors has appointed John (Jack) W. Crowley as the interim Chief Financial Officer and Treasurer of the Company and its subsidiaries, effective as of December 10, 2015, until a permanent Chief Financial Officer and Treasurer is appointed.
Mr. Crowley, age 51, had previously served as the Company’s Vice President, Chief Accounting Officer, a position he held since March 2015. Mr. Crowley held the position of Vice President, Finance from April 2013 until March 2015 and was Director, Accounting from September 2010 until April 2013. Prior to joining the Company, Mr. Crowley was the Assistant Corporate Controller of Biogen Idec, the Director of Accounting at Thermo Fischer Scientific and a Senior Manager in the Audit practice of PricewaterhouseCoopers LLP. Mr. Crowley holds a Master of Business Administration degree from the University of Massachusetts and a Bachelor of Science in Business Administration from Westfield State University.
In connection with Mr. Crowley’s appointment as interim Chief Financial Officer and Treasurer, he will be paid a supplemental bonus of $50,000 for each calendar quarter he serves as such, in addition to the compensation to which he is entitled under his existing employment agreement.
A copy of the Company’s press release, dated December 10, 2015, announcing the appointment of Mr. Crowley and the resignation of Mr. Bakewell is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
 
Item 9.01.	Financial Statements and Exhibits.	
(d) Exhibits

Exhibit
No.	  	Description	
 	 	
99.1	  	Press release of Lantheus Holdings, Inc. and Lantheus Medical Imaging, Inc., dated December 10, 2015, announcing the appointment of Jack Crowley and the resignation of John Bakewell.	

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

LANTHEUS HOLDINGS, INC.	
 	 	
By:	 	/s/ Michael P. Duffy	
Name:	 	Michael P. Duffy	
Title:	 	General Counsel and Senior Vice President, Strategy and Business Development	
Date: December 10, 2015

EXHIBIT INDEX

Exhibit
No.	  	Description	
 	 	
99.1	  	Press release of Lantheus Holdings, Inc. and Lantheus Medical Imaging, Inc., dated December 10, 2015, announcing the appointment of Jack Crowley and the resignation of John Bakewell.	

Exhibit 99.1

 	  	 	  	 	  	 	 	
 	  	 	  	 	  	 	 	 	
 	  	331 Treble Cove Road	  	 	  	800.362.2668	 	 	 	
 	  	North Billerica, MA 01862	  	 	  	www.lantheus.com	 	 	 	 	

CONTACT:
Meara Murphy
978-671-8508
LANTHEUS HOLDINGS ANNOUNCES APPOINTMENT OF
JACK CROWLEY AS INTERIM CHIEF FINANCIAL OFFICER
NORTH BILLERICA, Mass., (December 10, 2015) – Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), parent company of Lantheus Medical Imaging, Inc. (“LMI”), a global leader in developing, manufacturing, selling and distributing innovative diagnostic imaging agents and products, today announced the appointment of Jack Crowley as interim Chief Financial Officer, effective December 10, 2015. Mr. Crowley replaces John Bakewell, who has served as Chief Financial Officer since June 2014 and has resigned from the Company to accept another position.
Mr. Crowley, age 51, brings to the role more than 28 years of financial management and accounting experience. Since joining the Company in September 2010 as Director of Accounting, Mr. Crowley has steadily advanced to assume broader executive leadership roles. He was promoted to Vice President of Finance in April 2013 and to Chief Accounting Officer in March 2015. Mr. Crowley will report directly to Mary Anne Heino, President and Chief Executive Officer.
“I have had the pleasure of working with Jack for several years and have been impressed with his management of the Finance function,” said Ms. Heino. “Jack has consistently been a strong leader who has shown tremendous professional growth, and I am pleased that he will be taking on this role.”
“Jack is a highly skilled financial professional with deep knowledge of our business and industry,” said Sam Leno, Chairman of the Audit Committee of the Board. “I look forward to working with Jack as he takes on this new role.”
 
1

Mr. Crowley joined the Company from Biogen Idec where he served in the roles of Director of Finance and Assistant Corporate Controller and Director of External Reporting. Previously, Mr. Crowley was the Director of Accounting at Fisher Scientific International. Earlier in his career, he worked in serval public accounting firms, including as a Senior Manager in the Audit practice of PriceWaterhouseCoopers.
Mr. Crowley holds a Master of Business Administration from the University of Massachusetts and a Bachelor of Science in Business Administration from Westfield State University.
About Lantheus Holdings, Inc. and Lantheus Medical Imaging, Inc.
Lantheus Holdings, Inc. is the parent company of Lantheus Medical Imaging, Inc., which is a global leader in developing, manufacturing, selling and distributing innovative diagnostic imaging agents and products. LMI provides a broad portfolio of products, which are primarily used for the diagnosis of cardiovascular diseases. LMI’s key products include the echocardiography contrast agent DEFINITY ®  Vial for (Perflutren Lipid Microsphere) Injectable Suspension; TechneLite ®  (Technetium Tc99m Generator), a technetium-based generator that provides the essential medical isotope used in nuclear medicine procedures; and Xenon (Xenon Xe 133 Gas), an inhaled radiopharmaceutical imaging agent used to evaluate pulmonary function and for imaging the lungs. LMI is headquartered in North Billerica, Massachusetts, and has offices in Puerto Rico, Canada and Australia. For more information, visit  www.lantheus.com .
###
 
2